For example, anakinra is an FDA-approved recombinant IL-1R1 antagonist used to treat rheumatoid arthritis, neonatal onset multisystem inflammatory disease, and deficiency of interleukin-1 antagonist. The gene discussed is IL1R1; the disease is rheumatoid arthritis.